Chemist + Druggist is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


126 pre-regs to be recruited to NHS England's GP pharmacist scheme

Up to 126 training places have been reserved for pre-registration pharmacists to join NHS England’s “clinical pharmacist” programme, Health Education England has told C+D.

NHS England has already recruited more than 1,100 pharmacists to GP practices under the scheme, which it launched in 2015.

The trainees will be employed by community pharmacies or NHS trusts and will undertake three or six-month placements in general practices across England, HEE explained yesterday (May 8).

Pre-regs will be recruited via HEE’s centralised system – the national pre-registration pharmacist recruitment scheme – with applications opening on June 6, ready for trainees to start their placements in July and August 2019, it added.

Commenting on Twitter, NHS England clinical lead Ravi Sharma said the addition of pre-regs to the national pilot is “very good news”.

Have you considered a role as a practice pharmacist? Watch Ravi Sharma share his top tips for applying for a role in a GP surgery.

Would you consider a GP pharmacy role?

Related Content


Pharmacist Managers - Recruiting Now !
East London, Essex and Luton
£40,000 - £50,000 per year

Apply Now



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts